GAMMA Investing’s Redhill Biopharma RDHL Stock Holding History

GAMMA Investing’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$138	Sell	287 -6,670	-96%	-$4.33K	﹤0.01%	4297
2026 Q2	$5.88K	Buy	6,957 +273	+4%	+$252	﹤0.01%	3406
2026 Q1	$4.98K	Buy	6,684 +1,856	+38%	+$1.96K	﹤0.01%	3364
2025 Q4	$4.97K	Buy	4,828 +4,693	+3,476%	+$6.31K	﹤0.01%	3274
2025 Q3	$293	Sell	135 -1,926	-93%	-$3.14K	﹤0.01%	3767
2025 Q2	$4K	Sell	2,061 -1,507	-42%	-$3.07K	﹤0.01%	3206
2025 Q1	$9.49K	Sell	3,568 -1,521	-30%	-$7.09K	﹤0.01%	2766
2024 Q4	$31.6K	Buy	+5,089	New	+$38.9K	﹤0.01%	2009

GAMMA Investing's RDHL Position: Q3 2026 in Review

GAMMA Investing reduced its Redhill Biopharma (RDHL) stake by 96% in Q3 2026, selling an estimated $4.33K and leaving 287 shares worth $138. The position accounts for ﹤0.01% of the portfolio, ranked #4297.

GAMMA Investing first reported a position in RDHL in Q4 2024 and has held it in 8 quarters since. The position peaked at $31.6K in Q4 2024. 1 fund tracked by Wall St. Rank holds RDHL as of Q3 2026.

GAMMA Investing held 287 shares of Redhill Biopharma worth $138 as of Q3 2026.
GAMMA Investing sold 6,670 Redhill Biopharma shares in Q3 2026, an estimated $4.33K.
Redhill Biopharma made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4297 holding.
GAMMA Investing first reported a position in Redhill Biopharma in Q4 2024 and has held it in 8 quarters since.
GAMMA Investing's Redhill Biopharma position peaked at $31.6K in Q4 2024.
1 fund tracked by Wall St. Rank held Redhill Biopharma as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.